Rabbit Recombinant Monoclonal FBP1 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Recombinant full length protein - Human, Mouse, Rat samples. Cited in 24 publications.
View Alternative Names
FBP, FBP1, FBPase 1, Liver FBPase
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-FBP1 antibody [EPR4620] (AB109732)
Intracellular Flow Cytometry analysis of MCF7 (Human breast adenocarcinoma epithelial cell) cells labeling FBP1 with purified ab109732 at 1/400 dilution (1 μg/ml) (red). Cells were fixed with 4% Paraformaldehyde. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- ICC/IF
Collaborator
Immunocytochemistry/ Immunofluorescence - Anti-FBP1 antibody [EPR4620] (AB109732)
ICC/IF image of ab109732 stained HeLa cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab109732, 10μg/ml) overnight at +4°C. The secondary antibody (green) was ab96899, DyLight® 488 goat anti-rabbit IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-FBP1 antibody [EPR4620] (AB109732)
Immunocytochemistry/ Immunofluorescence analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling FBP1 with purified ab109732 at 1 : 50 dilution (7.9 µg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 µg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1 : 1000 (2 µg/ml) dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- WB
Unknown
Western blot - Anti-FBP1 antibody [EPR4620] (AB109732)
All lanes:
Western blot - Anti-FBP1 antibody [EPR4620] (ab109732) at 1/1000 dilution
Lane 1:
Human stomach lysate at 10 µg
Lane 2:
Human fetal liver lysate at 10 µg
Lane 3:
MCF7 lysate at 10 µg
Predicted band size: 37 kDa
false
- WB
Supplier Data
Western blot - Anti-FBP1 antibody [EPR4620] (AB109732)
Blocking buffer and concentration : 5% NFDM/TBST. Diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-FBP1 antibody [EPR4620] (ab109732) at 1/1000 dilution
Lane 1:
DDDK-tagged FBP1 human full-length recombinant protein at 15 ng
Lane 2:
DDDK-tagged FBP2 human full-length recombinant protein at 15 ng
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 37 kDa
Observed band size: 37 kDa
false
Exposure time: 5s
- WB
Lab
Western blot - Anti-FBP1 antibody [EPR4620] (AB109732)
All lanes:
Western blot - Anti-FBP1 antibody [EPR4620] (ab109732) at 1/50000 dilution
All lanes:
MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 37 kDa
Observed band size: 36 kDa
false
- WB
Lab
Western blot - Anti-FBP1 antibody [EPR4620] (AB109732)
All lanes:
Western blot - Anti-FBP1 antibody [EPR4620] (ab109732) at 1/1000 dilution
Lane 1:
Human kidney lysates at 20 µg
Lane 2:
Mouse liver lysates at 20 µg
Lane 3:
Mouse kidney lysates at 20 µg
Lane 4:
Rat liver lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 37 kDa
Observed band size: 36 kDa
false
Related conjugates and formulations (1)
-
Anti-FBP1 antibody [EPR4620] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The function of FBP1 involves maintaining glucose homeostasis which is essential for energy balance. FBP1 is part of the gluconeogenesis pathway a process that synthesizes glucose from non-carbohydrate sources. This enzyme acts independently and does not usually form part of larger protein complexes but its activity significantly impacts liver metabolism and energy production in low-glucose conditions.
Pathways
FBP1 finds its primary involvement in the gluconeogenesis pathway. This roles complements those of other enzymes such as phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase which also contribute to glucose synthesis. FBP1's activity supports glucose production providing glucose for bloodstream circulation when dietary intake is low.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (24)
Recent publications for all applications. Explore the full list and refine your search
Nature metabolism 7:1991-2003 PubMed40968275
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oncogenesis 14:11 PubMed40263262
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC medical genomics 18:17 PubMed39849455
2025
Applications
Unspecified application
Species
Unspecified reactive species
Translational andrology and urology 13:1991-2004 PubMed39434735
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cardiovascular diabetology 23:358 PubMed39395983
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nutrition & metabolism 19:78 PubMed36447227
2022
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 9:1701 PubMed34988210
2022
Applications
Unspecified application
Species
Unspecified reactive species
Central-European journal of immunology 46:427-437 PubMed35125940
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular oncology 16:1591-1607 PubMed34854226
2021
Applications
Unspecified application
Species
Unspecified reactive species
Computational and mathematical methods in medicine 2021:3334065 PubMed34221105
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com